Bildkälla: Stockfoto

Lifeclean Q3’22: Weak sales development - Redeye

Redeye saw sales substantially lower than our expectations for the quarter. The gross margin and Opex was in line with expectations. The slower sales development and increased risk-free rate in our model will lower our Base case and fair value range.

Redeye saw sales substantially lower than our expectations for the quarter. The gross margin and Opex was in line with expectations. The slower sales development and increased risk-free rate in our model will lower our Base case and fair value range.
Börsvärldens nyhetsbrev
ANNONSER